Severe cognitive disorders in patients with alcohol dependence: Clinical polymorphism and the possibilities of phosphocreatine treatment
Suggested citation:
Shapovalov DL, Shchukin IS, Shcherbak AN, et al. [Severe cognitive disorders in patients with alcohol dependence: Clinical polymorphism and the possibilities of phosphocreatine treatment]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2018;(3):53-60. Russian
In the controlled experiment, pursuing the goal of scientic substantaton of the efciency of phosphocreatne in the treatment of patents with alcohol dependence and severe cognitve disorders, we submit the results of the open comparatve randomized prospectve study. It has been established that phosphocreatne use increases the likelihood of decline in cognitve impairment from severe to moderate and reduces the duraton of treatment.
Keywords cognitive disorders; alcohol dependence; phosphocreatine
1. Zdravoohranenie v Rossii 2017: statisticheskiy sbornik. Moscow; 2017. 170 p. Russian. 2. Maslennikova GY, Oganov RG. Alkogol i risk razvitiya neinfektsionnyh zabolevaniy: strategii kontrolya v Rossiyskoy Federatsii. Kardovaskularnaya terapiya i profilaktika. 2013;12(4):3–8. Russian. 3. Vedder LC, Hall JM, Jabrouin KR, et al. Interactions between chronic ethanol consumption and thiamine deficiency on neural plasticity, spatial memory, and cognitive flexibility. Alcohol Clin Exp Res. 2015;39(11):2143–53. doi: 10.1111/acer.12859. 4. Vetreno RP, Hall JM, Savage LM. Alcohol-related amnesia and dementia: animal models have revealed the contributions of different etiological factors on neuropathology, neurochemical dysfunction and cognitive impairment. Neurobiol Learn Mem. 2011;96(4):596–608. doi: 10.1016/j.nlm.2011.01.003. 5. Odier C, Nguyen DK, Panisset M. Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis. J Neurol. 2010;257(7):1176–80. doi: 10.1007/s00415-010-5486-7. 6. Zaharov VV. Zloupotreblenie alkogolem: nevrologicheskie oslozhnenia I sovremennye podhody k terapii. Effektivnaya farmakoterapiya. 2014;(8):24. Russian. 7. Damulin IV. Kognitivnye rasstroystva pri alkogolizme. Russkiy meditsinskiy zhurnal. 2005;(12):785. Russian. 8. Damulin IV, Shmidt TE. Nevrologicheskie rasstroystva pri alkogolizme. Nevrologicheskiy zhurnal. 2004;9(2):4–10. Russian. 9. Sampson EL, Warren JD, Rossor MN. Young onset dementia. Postgrad Med J. 2004;80:125–39. 10. Adrianova ED, Damulin IV, Sivolap YP. Cognitivnye rasstroystva pri alcoholisme. Narcologia. 2013;(4):79–85. Russian. 11. Asada T, Takaya S, Takayama Y et al. Reversible alcohol-related dementia: a five-year follow-up study using FDG-PET and neuropsychological tests. Intern Med. 2010;49(4):283–87. 12. Psihicheskie rassroistva i rasstroistva povedeniya (F00–F99). Klass V MKB–10, adaptyrovanniy dlya ispolzovania v Rossiyskoy Federatsii. Moscow; 1998. 512 p. Russian. 13. Baranov AA. Federal’nye klinicheskie rekomendacii po okazaniyu meditsinskoy pomoschi detyam s hronicheskoy serdechnoy nedostatochnost’yu. Moscow; 2015. 20 p. Russian. 14. Baranov AA. Federal’nye klinicheskie rekomendacii po okazaniyu meditsinskoy pomoschi detyam s miocarditami. Moscow; 2015. 24 p. Russian. 15. Zhernakova NI. Kliniko-eksperimentalnoe issledovanie effectivnosti fosfocreatina pri ishemii miocarda. Nauchnye vedomosti. 2012;135(16):176–81. Russian. 16. Koshkin IV. Alkogolnoe porazhenie serdtsa: sovremennye podhody k terapii. Naberezhnye Chelny; 2001. 19 p. Russian. 17. Strumia E, Pellicia F, D’Ambrosio G. Phosphocreatine: pharmacological and clinical perspectives. Adv Ther. 2012;29(2):99–123. 18. Yakovlev VA. Kognitivnye rasstroystva v zrelom i pozhilom vozraste: psihologicheskie metody dignostiki. Moscow; 2011. 43 p. Russian. 19. Yahno NN, Shtul’mana DR. Bolezni nervnoi sistemy. Rukovodstvo dlya vrachey. V 2h tomah. T.1. Moscow; 2001. 743 p. Russian.
DOI: http://dx.doi.org/10.24411/1560-957X-2018-1%25x
Article Metrics
Metrics powered by PLOS ALM